Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 489,331 | 404,466 | 312,745 | 281,888 | 273,384 |
| Cost of Goods | 107,486 | 101,963 | 62,127 | 46,077 | 42,171 |
| Gross Profit | 381,845 | 302,503 | 250,618 | 235,811 | 231,213 |
| Operating Expenses | 240,817 | 214,278 | 207,943 | 205,921 | 199,285 |
| Operating Income | 141,514 | 89,188 | 42,802 | 29,967 | 32,099 |
| Interest Expense | 6,523 | 8,240 | 0 | 6 | 0 |
| Other Income | 725 | 3,246 | 565 | 2,104 | -156 |
| Pre-tax Income | 135,716 | 84,194 | 43,367 | 32,065 | 31,943 |
| Income Tax | 44,300 | 29,928 | 13,108 | 13,922 | 15,830 |
| Net Income Continuous | 91,416 | 54,266 | 30,259 | 18,143 | 16,113 |
| Net Income Discontinuous | -28,546 | -17,525 | N/A | N/A | N/A |
| Minority Interests | N/A | N/A | -876 | -5,381 | -6,906 |
| Net Income | $62,870 | $36,741 | $31,135 | $23,524 | $23,019 |
| EPS Basic Total Ops | 1.63 | 0.98 | 0.86 | 0.65 | 0.65 |
| EPS Basic Continuous Ops | 2.37 | 1.45 | 0.84 | 0.50 | 0.45 |
| EPS Basic Discontinuous Ops | -0.74 | -0.47 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.41 | 0.88 | 0.85 | 0.65 | 0.64 |
| EPS Diluted Continuous Ops | 2.02 | 1.26 | 0.82 | 0.50 | 0.45 |
| EPS Diluted Discontinuous Ops | -0.61 | -0.38 | N/A | N/A | N/A |
| EBITDA(a) | $176,849 | $121,641 | $61,760 | $41,164 | $41,454 |